|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Merck & Co., Inc. |
MRK |
58933Y105 |
Pharmaceuticals |
20,535 |
$2,377,747.65 |
8.20% |
| Johnson & Johnson |
JNJ |
478160104 |
Pharmaceuticals |
9,751 |
$2,344,140.40 |
8.09% |
| Bristol-Myers Squibb Company |
BMY |
110122108 |
Pharmaceuticals |
36,614 |
$2,207,458.06 |
7.62% |
| AbbVie Inc. |
ABBV |
00287Y109 |
Pharmaceuticals |
8,210 |
$1,889,203.10 |
6.52% |
| Pfizer Inc. |
PFE |
717081103 |
Pharmaceuticals |
69,767 |
$1,887,197.35 |
6.51% |
| Cardinal Health, Inc. |
CAH |
14149Y108 |
Pharmaceuticals |
5,805 |
$1,264,212.90 |
4.36% |
| Biogen Inc. |
BIIB |
09062X103 |
Biotechnology |
6,413 |
$1,185,571.31 |
4.09% |
| Eli Lilly and Company |
LLY |
532457108 |
Pharmaceuticals |
1,179 |
$1,167,599.07 |
4.03% |
| Viatris Inc. |
VTRS |
92556V106 |
Pharmaceuticals |
81,869 |
$1,159,265.04 |
4.00% |
| Regeneron Pharmaceuticals, Inc. |
REGN |
75886F107 |
Biotechnology |
1,487 |
$1,129,911.82 |
3.90% |
| Amgen Inc. |
AMGN |
031162100 |
Pharmaceuticals |
3,002 |
$1,109,329.06 |
3.83% |
| Gilead Sciences, Inc. |
GILD |
375558103 |
Pharmaceuticals |
7,631 |
$1,098,329.83 |
3.79% |
| Vertex Pharmaceuticals Incorporated |
VRTX |
92532F100 |
Pharmaceuticals |
2,206 |
$1,007,458.14 |
3.48% |
| United Therapeutics Corporation |
UTHR |
91307C102 |
Pharmaceuticals |
1,934 |
$924,761.44 |
3.19% |
| Jazz Pharmaceuticals Plc |
JAZZ |
G50871105 |
Pharmaceuticals |
4,052 |
$737,504.52 |
2.54% |
| Zoetis Inc. |
ZTS |
98978V103 |
Pharmaceuticals |
5,510 |
$669,079.30 |
2.31% |
| Illumina, Inc. |
ILMN |
452327109 |
Biotechnology |
4,296 |
$535,367.52 |
1.85% |
| Incyte Corporation |
INCY |
45337C102 |
Biotechnology |
4,358 |
$418,106.52 |
1.44% |
| PTC Therapeutics, Inc. |
PTCT |
69366J200 |
Biotechnology |
6,157 |
$386,782.74 |
1.33% |
| Charles River Laboratories International, Inc. |
CRL |
159864107 |
Biotechnology |
2,112 |
$368,459.52 |
1.27% |
| Exelixis, Inc. |
EXEL |
30161Q104 |
Biotechnology |
8,587 |
$356,746.96 |
1.23% |
| Arrowhead Pharmaceuticals, Inc. |
ARWR |
04280A100 |
Biotechnology |
5,325 |
$318,541.50 |
1.10% |
| Elanco Animal Health Incorporated |
ELAN |
28414H103 |
Pharmaceuticals |
13,348 |
$311,809.28 |
1.08% |
| BioMarin Pharmaceutical Inc. |
BMRN |
09061G101 |
Pharmaceuticals |
5,035 |
$307,739.20 |
1.06% |
| Medpace Holdings, Inc. |
MEDP |
58506Q109 |
Biotechnology |
576 |
$271,059.84 |
0.94% |
| Halozyme Therapeutics, Inc. |
HALO |
40637H109 |
Biotechnology |
3,280 |
$220,973.60 |
0.76% |
| Amneal Pharmaceuticals, Inc. |
AMRX |
03168L105 |
Pharmaceuticals |
16,087 |
$212,991.88 |
0.73% |
| Alkermes Plc |
ALKS |
G01767105 |
Pharmaceuticals |
7,280 |
$208,426.40 |
0.72% |
| Ionis Pharmaceuticals, Inc. |
IONS |
462222100 |
Pharmaceuticals |
2,753 |
$203,832.12 |
0.70% |
| Krystal Biotech, Inc. |
KRYS |
501147102 |
Biotechnology |
796 |
$201,937.24 |
0.70% |
| Protagonist Therapeutics, Inc. |
PTGX |
74366E102 |
Biotechnology |
1,988 |
$183,074.92 |
0.63% |
| Neurocrine Biosciences, Inc. |
NBIX |
64125C109 |
Biotechnology |
1,342 |
$171,950.46 |
0.59% |
| Guardant Health, Inc. |
GH |
40131M109 |
Biotechnology |
1,738 |
$158,505.60 |
0.55% |
| BridgeBio Pharma, Inc. |
BBIO |
10806X102 |
Biotechnology |
2,265 |
$148,040.40 |
0.51% |
| Ligand Pharmaceuticals Inc. (Class B) |
LGND |
53220K504 |
Biotechnology |
727 |
$146,781.30 |
0.51% |
| NewAmsterdam Pharma Company N.V. |
NAMS |
N62509109 |
Biotechnology |
4,879 |
$145,686.94 |
0.50% |
| Catalyst Pharmaceuticals, Inc. |
CPRX |
14888U101 |
Biotechnology |
5,862 |
$142,094.88 |
0.49% |
| Supernus Pharmaceuticals, Inc. |
SUPN |
868459108 |
Pharmaceuticals |
2,601 |
$140,115.87 |
0.48% |
| Mirum Pharmaceuticals, Inc. |
MIRM |
604749101 |
Biotechnology |
1,586 |
$136,871.80 |
0.47% |
| Prestige Consumer Healthcare Inc. |
PBH |
74112D101 |
Pharmaceuticals |
1,835 |
$123,293.65 |
0.43% |
| Insmed Incorporated |
INSM |
457669307 |
Biotechnology |
864 |
$121,072.32 |
0.42% |
| Madrigal Pharmaceuticals, Inc. |
MDGL |
558868105 |
Biotechnology |
269 |
$116,431.27 |
0.40% |
| TG Therapeutics, Inc. |
TGTX |
88322Q108 |
Biotechnology |
3,999 |
$117,050.73 |
0.40% |
| Rhythm Pharmaceuticals, Inc. |
RYTM |
76243J105 |
Biotechnology |
1,138 |
$106,425.76 |
0.37% |
| ADMA Biologics, Inc. |
ADMA |
000899104 |
Biotechnology |
6,798 |
$104,621.22 |
0.36% |
| ACADIA Pharmaceuticals Inc. |
ACAD |
004225108 |
Biotechnology |
4,517 |
$100,096.72 |
0.35% |
| Alnylam Pharmaceuticals, Inc. |
ALNY |
02043Q107 |
Biotechnology |
260 |
$83,371.60 |
0.29% |
| Tempus AI, Inc. (Class A) |
TEM |
88023B103 |
Biotechnology |
1,547 |
$80,846.22 |
0.28% |
| Perrigo Company Plc |
PRGO |
G97822103 |
Pharmaceuticals |
6,406 |
$68,672.32 |
0.24% |
| Corcept Therapeutics Inc. |
CORT |
218352102 |
Pharmaceuticals |
1,683 |
$57,003.21 |
0.20% |
| US Dollar |
$USD |
|
Other |
53,312 |
$53,311.59 |
0.18% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|